Copper amine oxidase from Hansenula polymorpha: the crystal structure determined at 2.4 A resolution reveals the active conformation

Structure
R LiF S Mathews

Abstract

Copper-containing amine oxidases (CAOs) are widespread in nature. These enzymes oxidize primary amine substrates to the aldehyde product, reducing molecular oxygen to hydrogen peroxide in the process. CAOs contain one type 2 copper atom and topaquinone (TPQ), a modified tyrosine sidechain utilized as a redox cofactor. The methylamine oxidase from the yeast Hansenula polymorpha (HPAO) is an isoform of CAO with a preference for small aliphatic amine or phenethylamine substrates. The enzyme is dimeric with a subunit molecular weight of 78 kDa. Structural studies are directed at understanding the basis for cofactor biogenesis and catalytic efficiency. The X-ray crystal structure of HPAO has been solved at 2.4 A resolution by a combination of molecular replacement and single isomorphous replacement followed by refinement using sixfold symmetry averaging. The electron density at the catalytic site shows that the TPQ conformation corresponds to that of the active form of the enzyme. Two channels, one on either side of TPQ, are observed in the structure that provide access between the active site and the bulk solvent. The structure shows TPQ in a position poised for catalysis. This is the first active CAO structure to reveal this confo...Continue Reading

References

Apr 1, 1992·Proteins·A L MorrisJ M Thornton
Jan 17, 1991·Nature·D M DooleyP F Knowles
Mar 1, 1991·Acta Crystallographica. Section A, Foundations of Crystallography·T A JonesM Kjeldgaard
Jul 28, 1986·FEBS Letters·S K Burley, G A Petsko
Feb 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·J L CrawfordC G Schellman
Jan 1, 1984·Progress in Biophysics and Molecular Biology·E N Baker, R E Hubbard
Jul 14, 1995·The Journal of Biological Chemistry·A J Tipping, M J McPherson
Jan 1, 1994·Annual Review of Biochemistry·J P Klinman, D Mu
Jan 1, 1995·Methods in Enzymology·C Hartmann, D M Dooley
Nov 1, 1994·Acta Crystallographica. Section D, Biological Crystallography·E A Merritt, M E Murphy
Sep 1, 1994·Acta Crystallographica. Section D, Biological Crystallography·UNKNOWN Collaborative Computational Project, Number 4
Mar 1, 1994·Acta Crystallographica. Section D, Biological Crystallography·G J Kleywegt, T A Jones
Jul 1, 1997·Acta Crystallographica. Section D, Biological Crystallography·R LiF S Mathews

❮ Previous
Next ❯

Citations

Jan 7, 2000·Biochemical and Biophysical Research Communications·P PietrangeliL Morpurgo
Jun 8, 2010·Molecular Genetics and Genomics : MGG·Yoshimoto SaitohChihiro Tanaka
Mar 10, 2001·Journal of Inorganic Biochemistry·J A Kucha, D M Dooley
Dec 26, 2001·Current Opinion in Structural Biology·H C Dawkes, S E Phillips
Apr 11, 2003·Biochimica Et Biophysica Acta·Judith P Klinman
Apr 11, 2003·Biochimica Et Biophysica Acta·P PietrangeliL Morpurgo
Apr 11, 2003·Biochimica Et Biophysica Acta·Rajeev PrabhakarBoris F Minaev
May 25, 2011·Biochemistry·Aaron P McGrathJ Mitchell Guss
Jun 28, 2008·Journal of the American Chemical Society·Arnab MukherjeeJustine P Roth
Sep 5, 2001·European Journal of Biochemistry·A PadigliaG Floris
Aug 7, 2007·Proceedings of the National Academy of Sciences of the United States of America·Jan SaamHartmut Kuhn
Apr 6, 2007·The Journal of Biological Chemistry·Bryan J JohnsonCarrie M Wilmot
Mar 3, 2006·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Emma JakobssonGerard J Kleywegt
Nov 2, 2006·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·David B LangleyJ Mitchell Guss
Dec 5, 2006·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Anthony P DuffJ Mitchell Guss
Jul 9, 2008·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·David B LangleyJ Mitchell Guss
Dec 5, 2008·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Pascale PirratSimon E V Phillips
Dec 9, 2010·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Karin ErnbergJ Mitchell Guss
Jun 14, 2012·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Valerie J KlemaCarrie M Wilmot
May 12, 2004·Biological Chemistry·Alessandra PadigliaRosaria Medda
Jul 4, 2012·International Journal of Molecular Sciences·Valerie J Klema, Carrie M Wilmot
Feb 18, 2014·Bioorganic & Medicinal Chemistry·Francesco LucchesiniFranca Buffoni
Nov 30, 2013·Plant & Cell Physiology·Maliwan NaconsieTakashi Hashimoto
Jun 23, 2006·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Isabel BentoPeter F Lindley
Aug 23, 2006·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Eric M Shepard, David M Dooley
Mar 1, 2012·Journal of Inorganic Biochemistry·Paola PietrangeliLaura Morpurgo
Feb 26, 2016·Biochemistry·Francesca SalviGiovanni Gadda
May 25, 2007·Journal of Inorganic Biochemistry·P PietrangeliL Morpurgo
Dec 19, 2006·Phytochemistry·William G HeimJohn G Jelesko
Jul 28, 2005·Protein Science : a Publication of the Protein Society·Tomi T AirenneTiina A Salminen
Aug 10, 2004·Chembiochem : a European Journal of Chemical Biology·Thomas C RosenGünter Haufe
Aug 20, 2003·Journal of Computational Chemistry·Rajeev Prabhakar, Per E M Siegbahn
Apr 17, 2007·The FEBS Journal·Anna MuraRosaria Medda
Feb 11, 2005·Journal of Molecular Biology·Michele LunelliGiuseppe Zanotti
Nov 10, 2004·Journal of Molecular Biology·Anthony P DuffJ Mitchell Guss

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.